The significance of ABC transporters in human placenta for the exposure of the fetus to xenobiotics

Reproductive and Developmental Toxicology

Volumn , Issue , 2011, Pages 1051-1065

  Vähäkangas, Kirsi H ^a   Veid, Jenni ^a   Karttunen, Vesa ^a   Partanen, Heidi ^a   Sieppi, Elina ^b   Kummu, Maria ^b   Myllynen, Päivi ^b   Loikkanen, Jarkko ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960924040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382032-7.10079-7     Document Type: Chapter

References (179)

1. Y.M. Abdulrazzaq, N. Osman and A. Ibrahim (2002) Fetal exposure to aflatoxins in the United Arab Emirates. Ann Trop Paediatr 22 3-9
2. R. Allikmets, L.M. Schriml, A. Hutchinson, V. Romano-Spica and M. Dean (1988) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58 5337-5339
3. K. Annola, A.T. Heikkinen, H. Partanen, H. Woodhouse, D. Segerbäck and K. Vähäkangas (2009) Transplacental transfer of nitrosodimethylamine in perfused human placenta. Placenta 30 277-283
4. K. Annola, V. Karttunen, P. Keski-Rahkonen, P. Myllynen, D. Segerbäck, S. Heinonen and K. Vähäkangas (2008) Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta. Toxicol Lett 182 50-56
5. T.I. Ala-Kokko, S. Alahuhta, P. Jouppila, K. Korpi, P. Westerling and K. Vähäkangas (1997) Feto-maternal distribution of ropivacaine and bupivacaine after epidural administration for cesarian section. Int J Obstet Anesth 6 147-152
6. T.I. Ala-Kokko, P. Myllynen and K. Vähäkangas (2000) Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int J Obstet Anesth 9 26-38
7. T.I. Ala-Kokko, P. Pienimäki, R. Herva, A.I. Hollmén, O. Pelkonen and K. Vähäkangas (1995) Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. Pharmacol Toxicol 77 142-148
8. T.I. Ala-Kokko, P. Pienimäki, E. Lampela, A.I. Hollmén, O. Pelkonen and K. Vähäkangas (1997) Transfer of clonidine and dexmedetomidine across the isolated perfused human placenta. Acta Anaesthesiol Scand 41 313-319
9. D.E. Atkinson, S.L. Greenwood, C.P. Sibley, J.D. Glazier and L.J. Fairbairn (2003) Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am J Physiol Cell Physiol 285 C584-C591
10. D.E. Atkinson, C.P. Sibley, L.J. Fairbairn and S.L. Greenwood (2006) MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction. Placenta 27 707-714
11. K.J. Bailey-Dell, B. Hassel, L.A. Doyle and D.D. Ross (2001) Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 1520 234-241
12. B. Balakrishnan, K. Henare, E.B. Thorstensen, A.P. Ponnampalam and M.D. Mitchell (2010) Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202 393. e1–e7
13. D. Balayssac, N. Authier, A. Cayre and F. Coudore (2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett 156 319-329
14. D.B. Barr, A. Bishop and L.L. Needham (2007) Concentrations of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 23 260-266
15. J. Behravan and M. Piquette-Miller (2007) Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol 3 819-830
16. K. Benirschke, P. Kaufmann and Baergen (2006) Pathology of the Human Placenta. New York: Springer
17. B.J. Bliek, R.H. van Schaik, I.P. van der Heiden, F.A. Sayed-Tabatabaei, C.M. van Duijn, E.A. Steegers and R.P. Steegers-Theunissen (2009) Eurocran Gene-Environment Interaction Group: Maternal medication use, carriership of the ABCB1 3435C>T polymorphism and the risk of a child with cleft lip with or without cleft palate. Am J Med Genet Part A 149A 2088-2092
18. C.J. Bode, H. Jin, E. Rytting, P.S. Silverstein, A.M. Young and K.L. Audus (2006) In vitro models for studying trophoplast transcellular transport. Methods Mol Med 122 225-239
19. P. Borst and R.O. Elferink (2002) Mammalian ABC transporters in health and disease. Ann Rev Biochem 71 537-592
20. J.M. Brandes, M.N. Tavoloni, B.J. Potter, L. Sarkozi, M.D. Shepard and P.D. Berk (1983) A new recycling technique for human placental cotyledon perfusion: application to studies of the fetomaternal transfer of glucose, inulin and antipyrine. Am J Obstet Gynecol 146 800-806
21. I. Caniggia, C.V. Taylor, J.W. Ritchie, S.J. Lye and M. Letarte (1997) Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138 4977-4988
22. A.F. Castoldi, N. Onishchenko, C. Johansson, T. Coccini, E. Roda, M. Vahter, S. Ceccatelli and L. Manzo (2008) Neurodevelopmental toxicity of methylmercury: laboratory animal data and their contribution to human risk assessment. Regul Toxicol Pharmacol 51 215-229
23. F.S. Chung, S. Eyal, M. Muzi, J.M. Link, D.A. Mankoff, A. Kaddoumi, F. O'Sullivan, P. Hsiao and J.D. Unadkat (2010) Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate. Br J Pharmacol 159 394-404
24. L.D. Coles, I.J. Lee, H.E. Hassan and N.D. Eddington (2009) Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J Pharma Sci 98 2832-2846
25. G. Conseil, R.G. Deeley and S.P.C. Cole (2005) Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogen Genom 15 523-533
26. L.H. Cygalova, J. Hofman, M. Ceckova and F. Staud (2009) Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J Pharmacol Exp Ther 331 1118-1125
27. J. Dancis (1985) Why perfuse the human placenta. Contrib Gynecol Obstet 13 1-4
28. U.G. Das, H. Sadiq, M.J. Soares, W.W. Hay Jr. and S.U. Devaskar (1998) Time-dependent physiological regulation of rodent and ovine placental glucose transporter (GLUT-1) protein. Am J Physiol 274 R339-R347
29. D.W. Denning, R. Allen, A.P. Wilkinson and M.R. Morgan (1990) Transplacental transfer of aflatoxin in humans. Carcinogenesis 11 1033-1035
30. A. Devault and P. Gros (1990) Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10 1652-1663
31. S. Di Santo, A. Malek, R. Sager, A.C. Andres and H. Schneider (2003) Trophoblast viability in perfused term placental tissue and explant cultures limited to 7–24 hours. Placenta 24 882-894
32. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi and D.D. Ross (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95 15665-15670
33. A.D. Earhart, S. Patrikeeva, X. Wang, D.R. Abdelrahman, G.D. Hankins, M.S. Ahmed and T. Nanovskaya (2009) Transplacental transfer and metabolism of bupropion. J Maternal-Fetal Neonatal Med 31 1-10
34. B. Ebert, A. Seidel and A. Lampen (2005) Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26 1754-1763
35. G. Englund, A. Jacobson, F. Rorsman, P. Artursson, A. Kindmark and A. Rönnblom (2007) Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 13 291-297
36. D.A. Evseenko, P. Murthi, J.W. Paxton, G. Reid, B.S. Emerald, K.M. Mohankumar, P.E. Lobie, S.P. Brennecke, B. Kalionis and J.A. Keelan (2007) The ABC transporter BCRP/ABCG2 is a placental survivor factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J 21 3592-3605
37. D.A. Evseenko, J.W. Paxton and J.A. Keelan (2006) ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290 R1357-R1365
38. M.F. Fromm (2002) Genetically determined differences in P-glycoprotein function: implications for disease risk. Toxicology 181 –182 299-303
39. T.C. Furesz, E. Heath-Monnig, S.G. Kamath and C.H. Smith (2002) Lysine uptake by cloned hCAT-2B: comparison with hCAT-1 and with trophoblast surface membranes. J Membr Biol 189 27-33
40. V. Ganapathy, Y.J. Fei and P.D. Prasad (2006) Heterologous expression systems for studying placental transporters. Methods Mol Med 122 285-300
41. L. Gavard, D. Beghin, F. Forestier, Y. Cayre, G. Peytavin, L. Mandelbrot, R. Farinotti and S. Gil (2009) Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir. Eur J Obstet Gynecol Reprod Biol 147 157-160
42. C. Gedeon, G. Anger, M. Piquette-Miller and G. Koren (2008) Breast cancer resistance protein: mediating the trans-placental transfer of glypuride across the human placenta. Placenta 29 39-43
43. O. Genbacev, S.A. Schubach and R.K. Miller (1992) Villous culture of first trimester human placenta – model to study extravillous trophoblast (EVT) differentiation. Placenta 13 439-461
44. I.M. Ghobrial and S.V. Rajkumar (2003) Management of thalidomide toxicity. J Support Oncol 1 194-205
45. S. Gil, R. Saura, F. Forestier and R. Farinotti (2005) P-glycoprotein expression of the human placenta during pregnancy. Placenta 26 268-270
46. P.D. Gluckman, M.A. Hanson, C. Cooper and K.L. Thornburg (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359 61-73
47. D.M. Guvenius, A. Aronsson, G. Ekman-Ordeberg, A. Bergman and K. Nóren (2003) Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenyols, and pentachlorophenol. Environ Health Persp 111 1235-1241
48. N. Hanet, A. Lancon, D. Delmas, B. Jannin, M.C. Chagnon, M. Cherkaoui-Malki, N. Latruffe, Y. Artur and J.M. Heydel (2008) Effects of endocrine disruptors on genes associated with 17beta-estradiol metabolism and excretion. Steroids 73 1242-1251
49. S.J. Heaton, J.J. Eady, M.L. Parker, K.L. Gotts, J.R. Dainty, S.J. Fairweather-Tait, H.J. McArdle, K.S. Srai and R.M. Elliott (2008) The use of BeWo cells as an in vitro model for placental iron transport. Am J Physiol Cell Physiol 295 C1445-C1453
50. S.J. Hemauer, T.N. Nonovskaya, S.Z. Abdel-Rahman, S.L. Patrikeeva, G.D. Hankins and M.S. Ahmed (2010) Modulation of human placental P-glycoprotein expression and activity MDR1 gene polymorphisms. Biochem Pharmacol 79 921-925
51. S.J. Hemauer, S.L. Patrikeeva, T.N. Nanovskaya, G.D. Hankins and M.S. Ahmed (2009) Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles. Biochem Pharmacol 78 1272-1278
52. D.G. Hemmings, B. Lowen, R. Sherburne, G. Sawicki and L.J. Guilbert (2001) Villous trophoblasts cultured on semi-permeable membranes form an effective barrier to the passage of high and low molecular weight particles. Placenta 22 70-79
53. M. Hitzl, E. Schaeffeler, B. Hocher, T. Slowinski, H. Halle, M. Eichelbaum, P. Kaufmann, P. Fritz, M.F. Fromm and M. Schwab (2004) Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics 14 309-318
54. G. Holcberg, O. Sapir, M. Tsadkin, M. Huleihel, S. Lazer, M. Katz, M. Mazor and Z. Ben-Zvi (2003) Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 109 133-137
55. L.L. Hsieh and T.T. Hsieh (1993) Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer Res 53 1278-1280
56. M. Huls, F.G. Russel and R. Masereeuw (2009) The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 328 3-9
57. J. Idänpään-Heikkilä, P. Jouppila, H.K. Akerblom, R. Isoaho, E. Kauppila and M. Koivisto (1972) Elimination and metabolic effects of ethanol in mother, fetus, and newborn infant. Am J Obstet Gynecol 112 387-393
58. F. Ietta, N. Bechi, R. Romagnoli, J. Bhattacharjee, M. Realacci, M. Di Vito, C. Ferretti and L. Paulesu (2010) 17β-estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta. Am J Physiol Endocrinol Metab 298 E411-E418
59. I. Ifergan, A. Shafran, G. Jansen, J.H. Hooijberg, G.L. Scheffer and Y.G. Assaraf (2004) Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem 279 25527-25534
60. Y. Imai, M. Nakane, K. Kage, S. Tsukahara, E. Ishikawa, T. Tsuruo, Y. Miki and Y. Sugimoto (2002) C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Therap 1 611-616
61. E. Immonen, R. Serpi, K. Vähäkangas and P. Myllynen (2009) Responses of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in MCF-7 cells are culture condition dependent. Chemico-Biol Interact 182 73-83
62. H. Jin and K.L. Audus (2005) Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta 26 S96-S103
63. P.M. Jones, M.L. O'Mara and A.M. George (2009) ABC transporters: a riddle wrapped in a mystery inside an enigma. Trends Biochem Sci 34 520-531
64. J.W. Jonker, G. Merino, S. Musters, A.E. van Herwaarden, E. Bolscher, E. Wagenaar, E. Mesman, T.C. Dale and A.H. Schinkel (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Med 11 127-129
65. G.M. Kalabis, S. Petropoulos, W. Gibb and S.G. Matthews (2009) Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone. Can J Physiol Pharmacol 87 973-978
66. M. Kippler, A.M. Hoque, R. Raqib, H. Ohrvik, E.C. Ekström and M. Vahter (2010) Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus. Toxicol Lett 192 162-168
67. T. Kitano, H. Iizasa, I.W. Hwang, Y. Hirose, T. Morita, T. Maeda and E. Nakashima (2004) Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood–placenta barrier. Biol Pharmaceut Bull 27 753-759
68. S. Kitsiou-Tzeli, J. Traeger-Synodinos, E. Giannatou, P. Kaminopetros, E. Roma, P. Makrythanasis and A. Tsezou (2009) The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 gene as a predisposing factor for intrahepatic cholestasis of pregnancy in Greece. Liver Int Epub
69. C.D. Klaassen and H. Lu (2008) Xenobiotic transporters: ascribing function from gene knockout and mutation studies. Toxicol Sci 101 186-196
70. H.J. Kliman, J.E. Nestler, E. Sermasi, J.M. Sanger and J.F. Strauss 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118 1567-1582
71. G.T. Knipp, B. Liu, K.L. Audus, H. Fuji, T. Ono and M.J. Soares (2000) Fatty acid transport regulatory proteins in the developing rat placenta and in trophoblast cell culture models. Placenta 21 367-375
72. D. Kobayashi, I. Ieiri, T. Hirota, H. Takane, S. Maegawa, J. Kigawa, H. Suzuki, E. Nanba, M. Oshimura, N. Terakawa, K. Otsubo, K. Mine and Y. Sugiyama (2005) Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 33 94-101
73. D. Kolwankar, D.D. Glover, J.A. Ware and T.S. Tracy (2005) Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab Dispos 33 524-529
74. J. Kraemer, J. Klein, A. Lubetsky and G. Koren (2006) Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety. Am J Obstet Gynecol 195 270-274
75. P. Krishnamurthy and J.D. Schuetz (2006) Role of ABCG2/BCRP in biology and medicine. Ann Rev Pharmacol Toxicol 46 381-410
76. E.S. Lampela, L.H. Nuutinen, T.I. Ala-Kokko, R.M. Parikka, R.S. Laitinen, P.I. Jouppila and K.H. Vähäkangas (1999) Placental transfer of sulindac, sulindac sulfide and indomethacin in human placental perfusion model. Am J Obstet Gynecol 180 174-180
77. G.R. Lankas, L.D. Wise, M.E. Cartwright and T. Pippert (1998) Umbenhauer DR: placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12 457-463
78. Y.J. Lee, H.Y. Ryu, H.K. Kim, C.S. Min, J.H. Lee, E. Kim, B.H. Nam, J.H. Park, J.Y. Jung, D.D. Jang, E.Y. Park, K.H. Lee, J.Y. Ma, H.S. Won, M.W. Im, J.H. Leem, Y.C. Hong and H.S. Yoon (2008) Maternal and fetal exposure to bisphenol A in Korea. Reprod Toxicol 25 413-419
79. R. Leiser and P. Kaufmann (1994) Placental structure: in a comparative aspect. Exp Clin Endocrinol 102 122-134
80. C. Lemos, I. Kathmann, E. Giovannetti, H. Dekker, G.L. Scheffer, C. Calhau, G. Jansen and G.J. Peters (2008) Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells. Int J Cancer 123 1712-1720
81. E.M. Leslie, R.G. Deeley and S.P. Cole (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204 216-237
82. F. Liu, M.J. Soares and K.L. Audus (1997) Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol 273 C1596-C1604
83. C. Loibichler, J. Pichler, M. Gerstmayr, B. Bohle, H. Kisst, R. Urbanek and Z. Szepfalusi (2002) Materno-fetal passage of nutritive and inhalant allergens across placentas of term and pre-term deliveries perfused in vitro. Clin Exp Allergy 32 1546-1551
84. H.T. Lynch and J.W. Reich (1985) Diethylstilbestrol, genetics, teratogenesis, and tumor spectrum in humans. Med Hypotheses 16 315-332
85. A. Malek, C. Obrist, S. Wenzinger and U. von Mandach (2009) The impact of cocaine and heroin on the placental transfer of methadone. Reprod Biol Endocrinol 7 61
86. Q. Mao (2008) BCRP/ABCG2 in the placenta: expression, function and regulation. Pharmaceut Res 25 1244-1255
87. A.A. Mathias, J. Hitti and J.D. Unadkat (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regulat Integr Comp Physiol 289 R963-R969
88. L. Mathiesen, E. Rytting, T. Mose and L.E. Knudsen (2009) Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: effect of albumin in the perfusion medium. Basic Clin Pharmacol Toxicol 105 181-187
89. K. May, M. Grube, I. Malhotra, C.A. Long, S. Singh, K. Mandaliya, W. Siegmund, C. Fusch, H. Schneider and C.L. King (2009) Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. PLoS One 4 e7986
90. K. May, V. Minarikova, K. Linnemann, M. Zygmunt, H.K. Kroemer, C. Fusch and W. Siegmund (2008) Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta. Drug Metab Dispos 36 740-744
91. E. Meyer zu Schwabedissen H, M. Grube, A. Dreisbach, G. Jedlitschky, K. Meissner, K. Linnemann, C. Fusch, C.A. Ritter, U. Völker and H.K. Kroemer (2006) Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos: Biol Fate Chem 34 524-533
92. H.E. Meyer zu Schwabedissen, M. Grube, B. Heydrich, K. Linnemann, C. Fusch, H.K. Kroemer and G. Jedlitschky (2005) Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. Am J Pathol 166 39-48
93. H.E. Meyer zu Schwabedissen, G. Jedlitschky, M. Gratz, S. Haenisch, K. Linnemann, C. Fusch, I. Cascorbi and H.K. Kroemer (2005) Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab Dispos: Biol Fate Chem 33 896-904
94. S.A. Missmer, L. Suarez, M. Felkner, E. Wang, A.H. Merrill Jr., K.J. Rothman and K.A. Hendricks (2006) Exposure to fumonisins and the occurrence of neural tube defects along the Texas–Mexico border. Environ Health Perspect 114 237-241
95. M. Mölsä, T. Heikkinen, J. Hakkola, K. Hakala, O. Wallerman, M. Wadelius, C. Wadelius and K. Laine (2005) Functional role of P-glycoprotein in the human blood–placental barrier. Clin Pharmacol Ther 78 123-131
96. R. Morris Buus and F.R. Boockfor (2004) Transferrin expression by placental trophoblastic cells. Placenta 25 45-52
97. T. Mose, L.E. Knudsen, M. Hedegaard and G.K. Mortensen (2007) Transplacental transfer of monomethyl phthalate and mono(2-ethylhexyl) phthalate in a human placenta perfusion system. Int J Toxicol 26 221-229
98. P. Myllynen, E. Immonen, M. Kummu and K. Vähäkangas (2009) Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 5 1483-1499
99. P. Myllynen, M. Kummu, T. Kangas, M. Ilves, E. Immonen, J. Rysä, R. Pirilä, A. Lastumäki and K. Vähäkangas (2008) ABCG2/BCRP decreases the transfer of a food-borne chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 232 210-217
100. P. Myllynen, P. Pienimäki, P. Jouppila and K. Vähäkangas (2001) Transplacental passage of oxcarbazepine and its metabolites in vivo. Epilepsia 42 1482-1485
101. P.K. Myllynen, P.K. Pienimäki and K.H. Vähäkangas (2003) Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo. Eur J Clin Pharmacol 58 677-682
102. P. Myllynen and K. Vähäkangas (2002) An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam. J Pharmacol Toxicol Method 48 131-138
103. M. Nagashige, F. Ushigome, N. Koyabu, K. Hirata, M. Kawabuchi, T. Hirakawa, S. Satoh, K. Tsukimori, H. Nakano, T. Uchiumi, M. Kuwano, H. Ohtani and Y. Sawada (2003) Basal membrane localization of MRP1 in human placental trophoblast. Placenta 24 951-958
104. T.N. Nanovskaya, I.A. Nekhayeva, G.D. Hankins and M.S. Ahmed (2008) Transfer of methadone across the dually perfused preterm human placental lobule. Am J Obstet Gynecol 198 126. e1–e4
105. T. Nanovskaya, I. Nekhayeva, N. Karunaratne, K. Audus, G.D. Hankins and M.S. Ahmed (2005) Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 69 1869-1878
106. H. Nau (1986) Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect 70 113-129
107. M. Nishimura and S. Naito (2005) Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokin 20 452-477
108. D. Novak, F. Quiggle, C. Artime and M. Beveridge (2001) Regulation of glutamate transport and transport proteins in a placental cell line. Am J Physiol 281 C1014-C1022
109. I. Öhman, S. Vitols and T. Tomson (2005) Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 46 1621-1624
110. H. Omi, A. Okamoto, T. Nikaido, M. Urashima, R. Kawaguchi, N. Umehara, K. Sugiura, M. Saito, T. Kiyono and T. Tanaka (2009) Establishment of an immortalized human extravillous trophoblast cell line by retroviral infection of E6/E7/hTERT and its transcriptional profile during hypoxia and reoxygenation. Int J Mol Med 23 229-236
111. O.A. Olivero, R. Parikka, M.C. Poirier and K. Vähäkangas (1999) 3′-azido-3′-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutation Res 428 41-47
112. H.Y. Park, J.S. Park, E. Sovcikova, A. Kocan, L. Linderholm, A. Bergman, T. Trnovec and I. Hertz-Picciotto (2009) Exposure to hydroxylated polychlorinated biphenyls (OH-PCBs) in the prenatal period and subsequent neurodevelopment in eastern Slovakia. Environ Health Perspect 117 1600-1606
113. S. Parry and J. Zhang (2007) Multidrug resistance proteins affect drug transmission across the placenta. Am J Obstet Gynecol 196 476. e1–476.e6
114. H. Partanen, H. El-Nezami, J. Leppänen, P. Myllynen, H. Woodhouse and K. Vähäkangas (2010) Aflatoxin B1 transfer and metabolism in human placenta. Toxicol Sci 113 216-225
115. L. Pascolo, C. Fernetti, M.V. Garcia-Mediavilla, J.D. Ostrow and C. Tiribelli (2001) Mechanisms for the transport of unconjugated biliruhin in human trophoplastic BeWo cells. FEBS Lett 495 94-99
116. L. Pascolo, C. Fernetti, D. Pirulli, S. Crovella, A. Amoroso and C. Tiribelli (2003) Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun 303 259-265
117. J.E. Paulsen, I.L. Steffensen, A. Andreassen, R. Vikse and J. Alexander (1999) Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 20 1277-1282
118. P. Pavek, L. Cerveny, L. Svecova, M. Brysch, A. Libra, R. Vrzal, P. Nachtigal, F. Staud, J. Ulrichova, Z. Fendrich and Z. Dvorak (2007) Examination of glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. Placenta 28 1004-1011
119. P. Pavek, Z. Fendrich, F. Staud, J. Malakova, H. Brozmanova, M. Laznicek, V. Semecky, M. Grundmann and V. Palicka (2001) Influence of P-glycoprotein on the transplacental passage of cyclosporine. J Pharmacol Sci 90 1583-1592
120. P. Pavek, G. Merino, E. Wagenaar, E. Bolscher, M. Novotna, J.W. Jonker and A.H. Schinkel (2005) Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312 144-152
121. P. Pavek, F. Staud, Z. Fendrich, H. Sklenarova, A. Libra, M. Novotna, M. Kopecky, M. Nobilis and V. Semecky (2003) Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J Pharmacol Exp Therap 305 1239-1250
122. M.G. Petroff, T.A. Phillips, H. Ka, J.L. Pace and J.S. Hunt (2006) Isolation and culture of term human trophoblast cells. Methods Mol Med 121 203-217
123. S. Petropoulos, G.M. Kalabis, W. Gibb and S.G. Matthews (2007) Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 14 321-328
124. V. Petrovic, S. Teng and M. Piquette-Miller (2007) Regulation of drug transporters during infection and inflammation. Mol Interv 7 99-111
125. P. Pienimäki, A.L. Hartikainen, P. Arvela, T. Partanen, R. Herva, O. Pelkonen and K. Vähäkangas (1995) Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsia 36 241-248
126. P. Pienimäki, E. Lampela, J. Hakkola, P. Arvela, H. Raunio and K. Vähäkangas (1997) Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia 38 309-316
127. E. Pollex, A. Lubetsky and G. Koren (2008) The role of placental breast cancer resistance protein in the efflux of glypuride across the human placenta. Placenta 29 743-747
128. E.K. Pollex, G. Anger, J. Hutson, G. Koren and M. Piquette-Miller (2010) Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos Biological Fate of Chem 38 740-744
129. B.M. Polliotti, R. Holmes, J.D. Cornish, M. Hulsey, S. Keesling, D. Schwartz, C.R. Abramowsky, J. Huddleston, M. Panigel and A.J. Nahmias (1996) Long-term dual perfusion of isolated human placental lobules with improved oxygenation for infectious diseases research. Placenta 17 57-68
130. C. Prouillac, B. Videmann, M. Mazallon and S. Lecoeur (2009) Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo). Toxicology 263 100-107
131. M. Rahi, T. Heikkinen, J. Hakkala, K. Hakala, O. Wallerman, M. Wadelius, C. Wadelius and K. Laine (2008) Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta. Hum Exp Toxicol 27 65-71
132. M.M. Rahi, T.M. Heikkinen, K.E. Hakala and K.P. Laine (2009) The effect of probenecid and MK-571 on the feto-maternal transfer of saquinar in dually perfused human term placenta. Eur J Pharm Sci 37 588-592
133. M. Rahi, T. Heikkinen, S. Härtter, J. Hakkola, K. Hakala, O. Wallerman, M. Wadelius, C. Wadelius and K. Laine (2007) Placental transfer of quetiapine in relation to P-glycoprotein activity. J Psychopharmacol 21 751-756
134. D.C. Rees, E. Johnson and O. Lewinson (2009) ABC transporters: the power to change. Nature Rev Mol Cell Biol 10 218-227
135. R.W. Robey, K.K. To, O. Polgar, M. Dohse, P. Fetsch, M. Dean and S.E. Bates (2009) ABCG2: a perspective. Adv Drug Deliv Rev 61 3-13
136. S. Saito, A. Iida, A. Sekine, Y. Miura, C. Oqawa, S. Kawauchi, S. Higuchi and Y. Nakamura (2002) Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR). J Hum Genet 47 147-171
137. B.V.R. Sastry (1999) Techniques to study human placental transport. Adv Drug Del Rev 38 17-39
138. Z.E. Sauna, I.W. Kim and S.V. Ambudkar (2007) Genomics and the mechanism of P-glycoprotein (ABCB1). J Bioenerg Biomembr 39 481-487
139. T. Schettgen, B. Kütting, M. Hornig, M.W. Beckmann, T. Weiss, H. Drexler and J. Angerer (2004) Trans-placental exposure of neonates to acrylamide – a pilot study. Int Arch Occup Environ Health 77 213-216
140. A.H. Schinkel and J.W. Jonker (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Ad Drug Deliv Rev 55 3-29
141. H. Schneider, M. Panigel and J. Dancis (1972) Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114 822-828
142. G. Schönfelder, W. Wittfoht, H. Hopp, C.E. Talsness, M. Paul and I. Chahoud (2002) Parent bisphenol A accumulation in the human maternal–fetal–placental unit. Environ Health Perspect 110 A703-A707
143. M.A. Serrano, R.I. Macias, O. Briz, M.J. Monte, A.G. Blazquez, C. Williamson, R. Kubitz and J.J. Marin (2007) Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 28 107-117
144. F. Shi, M.J. Soares, M. Avery, F. Liu, X. Shang and K.L. Audus (1997) Permeability and metabolic properties of a trophoblast cell line (HRP-1) derived from normal rat placenta. Exp Cell Res 234 147-155
145. J.W. Smit, M.T. Huisman, O. van Tellingen, H.R. Wiltshire and A.H. Schinkel (1999) Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Inv 104 1441-1447
146. S.D. Soechitram, M. Athanasiadou, L. Hovander, A. Bergman and P.J. Sauer (2004) Fetal exposure to PCBs and their hydroxylated metabolites in a Dutch cohort. Environ Health Perspect 112 1208-1212
147. F. Sörgel, R. Weissenbacher, M. Kinzig-Schippers, A. Hofmann, M. Illauer, A. Skott and C. Landersdorfer (2002) Acrylamide: increased concentrations in homemade food and first evidence of its variable absorbtion from food, variable metabolism and placental and breast milk transfer in humans. Chemotherapy 48 267-274
148. F. Staud, Z. Vackova, K. Pospechova, P. Pavek, M. Ceckova, A. Libra, L. Cygalova, P. Nachtigal and Z. Fendrich (2006) Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 319 53-62
149. M. Sun, J. Kingdom, D. Baczyk, S.J. Lye, S.G. Matthews and W. Gibb (2006) Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27 602-609
150. J.M. Swanson, S. Entringer, C. Buss and P.D. Wadhwa (2009) Developmental origins of health and disease: environmental exposures. Sem Reprod Med 27 391-402
151. M.R. Syme, J.W. Paxton and J.A. Keelan (2004) Drug transfer and metabolism by the human placenta. Clin Pharmacokin 43 487-514
152. A. Tamura, Y. Onishi, R. An, S. Koshiba, K. Wakabayashi, K. Hoshijima, W. Priebe, T. Yoshida, S. Kometani, T. Matsubara, K. Mikuriya and T. Ishikawa (2007) In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. Drug Metab Pharmacokin 22 428-240
153. M. Tanabe, I. Ieiri, N. Nagata, K. Inoue, S. Ito, Y. Kanamori, M. Takahashi, Y. Kurata, J. Kigawa, S. Iguchi, N. Terakawa and K. Otsubo (2001) Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Therap 297 1137-1143
154. K. Tertti, U. Ekblad, T. Heikkinen, M. Rahi, T. Rönnemaa and K. Laine (2010) The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta. Eur J Pharm Sci 39 76-81
155. P.C. Turner, A.C. Collinson, Y.B. Cheung, Y. Gong, A.J. Hall, A.M. Prentice and C.P. Wild (2007) Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol 36 1119-1125
156. R. Ueki, T. Tatara, N. Kariya, N. Shimode and C. Tashiro (2009) Comparison of placental transfer of local anesthetics in perfusates with different pH values in a human cotyledon model. J Anesth 23 526-529
157. N. Utoguchi, G.A. Chandorkar, M. Avery and K.L. Audus (2000) Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol 14 217-224
158. K. Vähäkangas and P. Myllynen (2009) Drug transporters in the human blood–placental barrier. Br J Pharmacol 158 665-678
159. K. Vähäkangas and P. Myllynen (2006) Experimental methods to study human transplacental exposure to genotoxic agents. Mut Res 608 129-135
160. K. Vähäkangas, H. Raunio, M. Pasanen, P. Sivonen, S.S. Park, H.V. Gelboin and O. Pelkonen (1989) Comparison of the formation of benzo[a]pyrene diolepoxide–DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2. J Biochem Toxicol 4 79-86
161. M. Vahter, A. Akesson, B. Lind, U. Bjors, A. Schutz and M. Berglund (2000) Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord. Environ Res 84 186-194
162. A.E. van Herwaarden, E. Wagenaar, B. Karnekamp, G. Merino, J.W. Jonker and A.H. Schinkel (2006) Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. Carcinogenesis 27 123-130
163. A.E. van Herwaarden, E. Wagenaar, G. Merino, J.W. Jonker, H. Rosing, J.H. Beijnen and A.H. Schinkel (2007) Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol 27 1247-1253
164. S.S. Vaidya, S.W. Walsh and P.M. Gerk (2009) Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments. Mol Pharmaceut 6 1689-1702
165. M. Vore and M. Leggas (2008) Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression. Mol Pharmacol 73 613-615
166. M. Wada (2006) Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response. Cancer Lett 234 40-50
167. T. Wang, M. Chen, Y.E. Yan, F.Q. Xiao, X.L. Pan and H. Wang (2009) Growth retardation of fetal rats exposed to nicotine in utero: possible involvement of CYP1A1, CYP2E1, and P-glycoprotein. Environ Toxicol 24 33-42
168. Q. Wang, R. Strab, P. Kardos, C. Ferguson, J. Li, A. Owen and I.J. Hidalgo (2008) Application and limitation of inhibitors in drug-transporter interactions studies. Int J Pharmaceut 356 12-18
169. X.B. Wang, S.S. Wang, Q.F. Zhang, M. Liu, H.L. Li, Y. Liu, J.N. Wang, F. Zheng, L.Y. Guo and J.Z. Xiang (2010) Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep 23 211-215
170. H. Wang, L. Zhou, A. Gupta, R.R. Vethanayagam, Y. Zhang, J.D. Unadkat and Q. Mao (2006) Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290 E798-E807
171. R.M. Whyatt, D.B. Barr, D.E. Camann, P.L. Kinney, J.R. Barr, H.F. Andrews, L.A. Hoepner, R. Garfinkel, Y. Hazi, A. Reyes, J. Ramirez, Y. Cosme and F.P. Perera (2003) Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ Health Perspect 111 749-756
172. D.T. Wigle, T.E. Arbuckle, M. Walker, M.G. Wade, S. Liu and D. Krewski (2007) Environmental hazards: evidence for effects on child health. J Toxicol Environ Health Part B, Crit Rev 10 3-39
173. C.P. Wild, F.N. Rasheed, M.F. Jawla, A.J. Hall, L.A. Jansen and R. Montesano (1991) In-utero exposure to aflatoxin in west Africa. Lancet 337 1602
174. O.M. Woodward, A. Köttgen, J. Coresh, E. Boerwinkle, W.B. Guggino and M. Köttgen (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 106 10338-10342
175. K. Yanase, S. Tsukahara, J. Mitsuhashi and Y. Sugimoto (2006) Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development. Cancer Lett 234 73-80
176. S. Yasuda, S. Itagaki, T. Hirano and K. Iseki (2005) Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 69 1871-1876
177. D. Yeboah, M. Sun, J. Kingdom, D. Baczyk, S.J. Lye, S.G. Matthews and W. Gibb (2006) Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 84 1251-1258
178. F. Zhou, K. Tanaka, M.J. Soares and G. You (2003) Characterization of an organic anion transport system in a placental cell line. Am J Physiol 285 E1103-E1109
179. B. Zimmerli and R. Dick (1995) Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J Chromatogr B, Biomed Appl 666 85-99